A Trial of SHR-1703 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

September 21, 2021

Study Completion Date

September 21, 2021

Conditions

Asthma

Interventions

DRUG

SHR-1703

DRUG

Placebo

Placebo of the SHR-1703

Trial Locations (1)

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04480762 - A Trial of SHR-1703 in Healthy Adults | Biotech Hunter | Biotech Hunter